The psychological phenotype of females with fragile X syndrome (FraX) is discussed, focusing primarily on empirical findings over the past decade and on studies of probands with the full mutation (FM). A developmental approach is used to help characterize specific patterns of cognitive, neuropsychol
A converging-methods approach to fragile X syndrome
β Scribed by James D. Churchill; Aaron W. Grossman; Scott A. Irwin; Roberto Galvez; Anna Y. Klintsova; Ivan Jeanne Weiler; William T. Greenough
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 211 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0012-1630
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Converging approaches across domains of brain anatomy, cell biology, and behavior indicate that Fragile X syndrome, arising from impaired expression of a single gene and protein, appears to involve an aberration of normal developmental processes. Synapse overproduction and selective elimination, or pruning, characterize normal brain development. In autopsy tissue from Fragile X patients and in a knockout mouse model of the disease, synapse overproduction appears to occur unaccompanied by synapse pruning and maturation, leaving an excess of immature spine synapses in place. The absence of the Fragile X protein seems to impair the synthesis of important proteins at synapses. The developmental outcome in Fragile X is a nervous system that is relatively disorganized, resulting in disrupted perceptual, and cognitive social, behavior. Β© 2002 Wiley Periodicals, Inc. Dev Psychobiol 40: 323β338, 2002. DOI 10.1002/dev.10036
π SIMILAR VOLUMES
Fragile X syndrome is associated with the expansion of the number of CGG trinucleotide tandem repeats at the 5Β’ untranslated region of the FMR1 gene. The number of CGG trinucleotide repeats in normal individuals ranges between 5 and 50, in asymptomatic carrier individuals it ranges between 50 and 20
## Abstract Since the identification of the FMR1 gene basic research has been focused on the molecular characterization of the FMR1 gene product, the fragile X mental retardation protein (FMRP). Recent developments in fragile X research have provided new insights and knowledge about the physiologic